S. Nasir

1.4k total citations · 1 hit paper
6 papers, 1.1k citations indexed

About

S. Nasir is a scholar working on Cellular and Molecular Neuroscience, Endocrine and Autonomic Systems and Infectious Diseases. According to data from OpenAlex, S. Nasir has authored 6 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Cellular and Molecular Neuroscience, 2 papers in Endocrine and Autonomic Systems and 1 paper in Infectious Diseases. Recurrent topics in S. Nasir's work include Neuroscience and Neuropharmacology Research (2 papers), Cardiovascular, Neuropeptides, and Oxidative Stress Research (1 paper) and Neural dynamics and brain function (1 paper). S. Nasir is often cited by papers focused on Neuroscience and Neuropharmacology Research (2 papers), Cardiovascular, Neuropeptides, and Oxidative Stress Research (1 paper) and Neural dynamics and brain function (1 paper). S. Nasir collaborates with scholars based in United Kingdom, Malaysia and United States. S. Nasir's co-authors include Andrew D. Randall, D Smart, Janet L. Davis, Jeffrey C. Jerman, Martin J. Gunthorpe, Julie Gray, Jon Chambers, Guillaume Hervieu, Jackie Meakin and Peter R. Maycox and has published in prestigious journals such as Brain Research, British Journal of Pharmacology and European Journal of Neuroscience.

In The Last Decade

S. Nasir

5 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)

2000 637 citations D Smart, Martin J. Gunthorpe et al. British Journal of Pharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S. Nasir United Kingdom	4	450	429	393	347	310	6	1.1k
Pouya Movahed Sweden	10	684 1.5×	525 1.2×	447 1.1×	146 0.4×	378 1.2×	18	1.5k
Andrei V. Derbenev United States	21	203 0.5×	133 0.3×	220 0.6×	631 1.8×	390 1.3×	38	1.2k
Mary Lou Lubin United States	13	783 1.7×	199 0.5×	442 1.1×	66 0.2×	341 1.1×	16	1.2k
Nicole M. Breese United States	5	330 0.7×	306 0.7×	294 0.7×	82 0.2×	364 1.2×	5	1.0k
Perdita L. Pugh United Kingdom	8	1.1k 2.5×	160 0.4×	627 1.6×	84 0.2×	986 3.2×	8	1.8k
Mark O. Urban United States	17	409 0.9×	155 0.4×	396 1.0×	52 0.1×	487 1.6×	27	1.2k
Luciano De Petrocellis Italy	10	135 0.3×	1.2k 2.9×	682 1.7×	209 0.6×	148 0.5×	11	1.5k
Wende Niforatos United States	18	398 0.9×	113 0.3×	396 1.0×	336 1.0×	599 1.9×	28	1.7k
Young‐Ho Jin South Korea	15	172 0.4×	85 0.2×	309 0.8×	444 1.3×	197 0.6×	27	1.2k
David Immke United States	13	655 1.5×	61 0.1×	472 1.2×	135 0.4×	547 1.8×	16	1.7k

Countries citing papers authored by S. Nasir

Since Specialization

Citations

This map shows the geographic impact of S. Nasir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Nasir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Nasir more than expected).

Fields of papers citing papers by S. Nasir

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Nasir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Nasir. The network helps show where S. Nasir may publish in the future.

Co-authorship network of co-authors of S. Nasir

This figure shows the co-authorship network connecting the top 25 collaborators of S. Nasir. A scholar is included among the top collaborators of S. Nasir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Nasir. S. Nasir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Nasir, S., et al.. (2025). Executive function deficit in patients with long COVID syndrome: A systematic review. Heliyon. 11(3). e41987–e41987.

2.

Nasir, S., Noorazrul Yahya, & Hanani Abdul Manan. (2024). Functional brain alterations in COVID-19 patients using resting-state fMRI: a systematic review. Brain Imaging and Behavior. 18(6). 1582–1601. 2 indexed citations

3.

Gunthorpe, Martin J., Harshad K. Rami, Jeffrey C. Jerman, et al.. (2003). Identification and characterisation of SB-366791, a potent and selective vanilloid receptor (VR1/TRPV1) antagonist. Neuropharmacology. 46(1). 133–149. 220 indexed citations

4.

Meadows, H.J., C.G. Chapman, D. Malcolm Duckworth, et al.. (2001). The neuroprotective agent sipatrigine (BW619C89) potently inhibits the human tandem pore-domain K+ channels TREK-1 and TRAAK. Brain Research. 892(1). 94–101. 47 indexed citations

5.

Smart, D, Martin J. Gunthorpe, Jeffrey C. Jerman, et al.. (2000). The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1). British Journal of Pharmacology. 129(2). 227–230. 637 indexed citations breakdown →

6.

Hervieu, Guillaume, Jane E. Cluderay, David C. Harrison, et al.. (2000). The distribution of the mRNA and protein products of the melanin‐concentrating hormone (MCH) receptor gene, slc‐1, in the central nervous system of the rat. European Journal of Neuroscience. 12(4). 1194–1216. 244 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact